Efficacy of Combining, Sequencing Liver-directed Therapy With Systemic Therapy for Gastrointestinal NETs

Gaby Gabriel, MD, program director, interventional radiology residency and assistant program director, diagnostic radiology residency, University of Kentucky, discusses the findings regarding the efficacy of combining and sequencing liver-directed therapy with systemic therapy.

Pharmacy Times interviewed Gaby Gabriel, MD, program director, interventional radiology residency and assistant program director, diagnostic radiology residency, University of Kentucky, on his presentation at the 2021 NANETS Multidisciplinary Neuroendocrine Tumors (NETs) Medical Virtual Symposium discussing sequencing and combination of liver-directed therapy (LDT) with systemic therapies.

During the interview, Gabriel discussed the findings regarding the efficacy of combining and sequencing LDT with systemic therapy when treating patients with gastrointestinal NETs.

Related Videos
Conference attendees watching a speaker | Image credit: kasto - stock.adobe.com
Biosimilars | Image credit: lexiconimages - stock.adobe.com
Medical care team | Image credit: Iryna - stock.adobe.com
Pharmacist helping patient | Image credit: Zamrznuti tonovi - stock.adobe.com
Healthcare technology | Image credit: ipopba | stock.adobe.com
Pharmacist in home infusion environment | Image credit: Satjawat - stock.adobe.com
Related Content
© 2023 MJH Life Sciences

All rights reserved.